MedPath

Ibuprofen Lysine

These highlights do not include all the information needed to use Ibuprofen Lysine safely and effectively. See full prescribing information for Ibuprofen Lysine. Ibuprofen Lysine Injection, for intravenous use Initial U.S. Approval: 1974

Approved
Approval ID

307431c7-12de-21e5-e054-00144ff88e88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 5, 2024

Manufacturers
FDA

Prasco Laboratories

DUNS: 065969375

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ibuprofen lysine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66993-490
Application NumberNDA021903
Product Classification
M
Marketing Category
C73605
G
Generic Name
ibuprofen lysine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 31, 2023
FDA Product Classification

INGREDIENTS (2)

IBUPROFEN LYSINEActive
Quantity: 10 mg in 1 mL
Code: N01ORX9D6S
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ibuprofen Lysine - FDA Drug Approval Details